Both in Biotechnology
Bio-Techne vs Repligen
Over the past year TECH returned +38.6% and RGEN returned +56.8%; their daily moves had a correlation of 0.54.
TECH +38.6% RGEN +56.8%Growth of $1, one year, split-adjusted
| Metric | TECH | RGEN |
|---|---|---|
| Price | $72.38 | $194.57 |
| Market cap | $11.35B | $10.98B |
| Today | −0.18% | +0.25% |
| 1 month | 0.0% | +10.4% |
| 6 months | +39.1% | +74.5% |
| Year to date | +23.1% | +18.7% |
| 1 year | +39.6% | +54.9% |
| Revenue growth (YoY) | +1.3% | +11.9% |
| Gross margin | 65.8% | 53.9% |
| Net margin | 17.0% | 2.5% |
| P/E (TTM) | 62.4× | 264.3× |
| Price / sales | 9.3× | 14.0× |
| Net cash | $64.7M | $259.4M |
| Dividend yield | 0.44% | — |
| Volatility (60d) | 3.7% | 43.0% |
| Short % of float | 4.3% | 12.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).